Testing for the BRCA gene mutation in the Jewish community is now available from the NHS on a permanent basis – a landmark decision for the community. Chai is here to help anyone who tests positive navigate the complexities that follow.
In January 2023, when NHS England launched its BRCA testing programme for those with Jewish ancestry, it was a game-changing opportunity. Roughly one in 40 people with Ashkenazi Jewish ancestry and one in 140 people with Sephardi Jewish ancestry carry a BRCA1 or BRCA2 gene mutation, compared with around one in 250 people in the general population. Between 30 and 40 per cent of all ovarian cancers in the Jewish community are caused by a BRCA mutation and 10 per cent of all breast cancers. Either parent can pass on the BRCA mutation to their child.
[Missing Credit]
Before this programme, many carriers remained unidentified through traditional testing protocols because of a lack of cancer history in the family.
Over the three-year testing period, 45,000 people with at least one Jewish grandparent registered for the simple saliva test and 33,355 took it – a huge response rate. At time of going to press, 740 people have tested positive and now have the chance to make informed decisions for themselves and their families.
Beyond the individual impact, the pilot proves the benefits of shifting from reactive treatment to proactive prevention. Identifying BRCA carriers before cancer develops enables them to undergo regular monitoring and, where appropriate, opt for preventative surgery.
Professor Ranjit Manchanda, consultant gynaecological oncologist at Queen Mary University and a leading researcher in genetic cancer screening, who championed the initiative, says: “The Jewish BRCA testing programme leads to years gained and lives saved. Identifying a BRCA carrier after a cancer diagnosis is failure of cancer prevention.”
The test also ensures that the next generation can screen out the BRCA gene mutation through preimplantation genetic testing (PGT), a variant of IVF.
Chai’s services relating to BRCA include one-to-one and partner counselling as well as group support: for those with positive tests but no cancer, and for those with the BRCA mutation and a diagnosis.
“Clients need to discover what they feel about their positive result without pressure,” says clinical lead Zippora Galpert. “In a group, they hear how others are grappling with dilemmas such as telling siblings and children; preventative surgery versus monitoring. For those caught in the crosshairs of a positive result, Chai is the safe place where they can navigate this new territory.”
BRCA testing, the next phase
Community testing for the BRCA gene mutation is scheduled to start in September 2027.
Register at jewishbrca.programme@nhs.net
You can also call the NHS Jewish BRCA helplineon 020 3437 6001 (Mon to Fri, 9am to 5pm, Wed until 7pm).
The permanent programme will launch 2027/2028.
If you have a testing kit from the pilot period, return it by November 30, 2026 to ensure it is processed.
Alina Hackett’s story
“I was grateful to use the NHS testing programme. My mother and maternal grandmother both had breast cancer, and my mother tested positive for BRCA after her cancer diagnosis. I tested positive and turned to Chai for support. Although I would have preferred a negative result, knowing I was positive meant I could take control of my risk and be proactive about my care.
“I grew up in a Jewish community but now live outside one. I wanted the comfort of being with Jewish women who understood what I was facing. Through Chai’s group, I feel seen, understood and supported, and can support in return.
“Hearing different perspectives has given me greater confidence in my decisions and a clearer understanding of the process. I am grateful to every woman in the group, and to Chai for bringing us together. This journey would be far more stressful without them.”
For more information on Chai’s specialised services, call Charlotte Hildebrand on 020 8457 3238 or go to chaicancercare.org
